- Home
- LRE vs GNTA Comparison
LRE vs GNTA Comparison
Compare LRE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRE | GNTA |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | Japan | Italy |
| Employees | N/A | 9 |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 33.8M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LRE | GNTA |
|---|---|---|
| Price | $1.09 | $0.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.8K | ★ 53.6K |
| Earning Date | 07-30-2015 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.55 |
| 52 Week High | $1.86 | $10.00 |
Technical Indicators
Market Signals| Indicator | LRE | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 26.19 |
| Support Level | N/A | $0.58 |
| Resistance Level | $1.34 | $0.74 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 35.81 | 10.38 |
Price Performance
Historical ComparisonAbout LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is an industrial consolidator focused on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its acquisition activities span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity, with a focus on businesses covered by Italy's Golden Power legislation.